Valeant to Acquire Specialty Salix Pharma

Valeant to Acquire Specialty Salix Pharma

Valeant Pharmaceuticals has reached an agreement to acquire Salix Pharma in a cash deal that values the gastrointestinal drug company at $14.5 billion, the companies said Sunday. Under the definitive agreement, Valeant (NYSE:VRX) based near Montreal, Canada, will acquire Raleigh, NC-based Salix (NASDAQ: SLXP) for $158 per share, a modest premium given the stock’s $150.74 closing … Read moreValeant to Acquire Specialty Salix Pharma

Food Components and Irritable Bowel Syndrome

Food Components and Irritable Bowel Syndrome

Click Here To Read The Full Text Ingestion of food has long been linked with gut symptoms, and there is increasing interest in using diet in the management of patients with irritable bowel syndrome (IBS). The West has developed an intense interest in specialized, restrictive diets, such as those that target multiple food groups, avoid … Read moreFood Components and Irritable Bowel Syndrome

Probiotics for IBS – Irritable Bowel Syndrome

Probiotics for IBS - Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS) When disease-causing bacteria get a home in your gut, they can induce inflammation; damage the intestinal wall and set the stage for IBS. Research has revealed that probiotics can play a major role in resolving IBS and inflammatory bowel disease. RELATED: Top Rated Probiotics for IBS Acidophilus can also help to … Read moreProbiotics for IBS – Irritable Bowel Syndrome

IBD patients are misdiagnosed with irritable bowel syndrome IBS

IBD patients are misdiagnosed with irritable bowel syndrome IBS

A new study, published in the latest issue of the UEG Journal reveals that 10 percent of inflammatory bowel disease (IBD) patients are misdiagnosed with irritable bowel syndrome (IBS), and in 3 percent of cases the misdiagnosis can persist for five or more years. The case-controlled study, conducted in the UK, assessed the proportion of … Read moreIBD patients are misdiagnosed with irritable bowel syndrome IBS

New Guidelines Address Irritable Bowel Syndrome Drugs

New guidelines address irritable bowel syndrome drugs

Up to 15 percent of the general adult population is affected by irritable bowel syndrome (IBS), and most patients struggle to find effective drug therapy. A new guideline from the American Gastroenterological Association (AGA) provides these patients and their physician’s guidance. The new guideline and accompanying technical review have been published in Gastroenterology, the official … Read moreNew Guidelines Address Irritable Bowel Syndrome Drugs